Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.
Northway WH Jr, Rosan RC, Porter DY.
N Engl J Med. 1967 Feb 16;276(7):357-68. doi: 10.1056/NEJM196702162760701.
Hyaline membrane disease.
Farrell PM, Avery ME.
Am Rev Respir Dis. 1975 May;111(5):657-88. doi: 10.1164/arrd.1975.111.5.657.
Hyaline-membrane disease.
Pender CB.
N Engl J Med. 1971 Oct 7;285(15):861. doi: 10.1056/NEJM197110072851519.
Hyaline membrane disease (HMD): an historical and Oslerian perspective.
Malloy MH, McGovern JP.
J Perinatol. 2018 Dec;38(12):1602-1606. doi: 10.1038/s41372-018-0237-1. Epub 2018 Oct 5.
Pulmonary epithelial permeability in hyaline-membrane disease.
Jefferies AL, Coates G, O'Brodovich H.
N Engl J Med. 1984 Oct 25;311(17):1075-80. doi: 10.1056/NEJM198410253111703.
Historical perspective on surfactant therapy: Transforming hyaline membrane disease to respiratory distress syndrome.
Hallman M, Herting E.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101493. doi: 10.1016/j.siny.2023.101493. Epub 2023 Nov 22.
Pulmonary hyaline membrane disease. Pathogenesis.
KAGAN B.
Calif Med. 1960 Jan;92(1):4-5.
Hyaline-membrane disease, oxygen, and pulmonary fibroplasia.
[No authors listed]
Lancet. 1969 Jan 4;1(7584):32-3.
Hyaline membrane disease.
Vidyasagar D, Bhat R.
Obstet Gynecol Annu. 1977;6:223-45.
Surfactant.
Woolcock AJ.
Med J Aust. 1973 May 5;1(18):900-3. doi: 10.5694/j.1326-5377.1973.tb110777.x.
